Navigation Links
Poniard Pharmaceuticals to Present at the BIO CEO & Investor Conference
Date:2/3/2009

SOUTH SAN FRANCISCO, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and CEO, will present at the 11th Annual BIO CEO & Investor Conference 2009 on Tuesday, February 10, at 10 a.m. Eastern Time at the Waldorf-Astoria in New York.

Dr. McMahon will provide a corporate overview, including a discussion of the clinical development program for picoplatin, the Company's lead product candidate.

A live audio webcast of the presentation will be available for 10 business days on the "Events" page of the "News & Events" section of the Company's website at http://www.poniard.com.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc., is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum chemotherapy. To date, clinical studies suggest that picoplatin has an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors, and is being studied in multiple cancer indications, combinations and formulations. Clinical trials of intravenous picoplatin include a Phase 3 trial in small cell lung cancer and Phase 2 trials in metastatic colorectal and castration resistant prostate cancers (also known as hormone refractory prostate cancer), as well as a clinical trial of oral picoplatin in solid tumors. For additional information please visit h
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
2. Poniard Pharmaceuticals to Present Data from Phase 2 Clinical Trials of Picoplatin in Colorectal and Prostate Cancers
3. Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin
4. Poniard Pharmaceuticals to Host Third Quarter 2008 Financial Results Conference Call on October 30
5. Poniard Announces Positive Incremental Efficacy and Safety Data from Phase 2 Picoplatin Trial in Patients With Metastatic Colorectal Cancer
6. Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer
7. Poniard Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Poniard Pharmaceuticals Announces Upcoming Conference Participation
9. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
10. Poniard Pharmaceuticals Announces Upcoming Conference Participation
11. Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013  regulated information — Global biopharmaceutical ... today announced the launch of a new Pledge ... The Pledge empowers the millions ... and make a personal commitment to demand more: greater ... care team and additional partial-onset seizure control.  More information ...
(Date:6/18/2013)... ZIONA, Israel , June 18, 2013 /PRNewswire/ ... bulk Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and ... today that the company has been granted a ... in the US and Europe for ... Patent number 8,410,176 B2 is titled Intermediate Compounds and ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/4b8vj2/injectable_drug ) has announced the addition of ... Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables ... Free & Auto Injectors] & Therapeutics [Diabetes ... report to their offering. ...
(Date:6/18/2013)... Though health care jobs continued ... U.S. Bureau of Labor Statistics -- the increase was far ... Most new health care jobs were added in home health ... loss of 6,000 jobs. Overall, the U.S. unemployment rate stayed ... & Christmas reported that a total of just over 36,000 ...
Breaking Biology Technology:Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3
... CARLOS, Calif., Dec. 2 SleepQuest is proud to ... Joint Commission on the,Accreditation of Health Care Organizations (JCAHO) ... and safety. , ... of,national standards by The Joint Commission,s home care service ...
... Martek Biosciences Corporation (Nasdaq: MATK ) announced that it ... year 2008 on December 11, 2008, at approximately 4:00 p.m. Eastern ... will conduct a conference call to discuss these results with investors. ... webcast by visiting Martek,s web site at http://investors.martek.com . , ...
... On Track to File NDA with FDA in Early ... WOODCLIFF LAKE, N.J., Dec. 2 Strativa Pharmaceuticals, the ... PRX ) today announced that its development ... pivotal bioequivalence studies for a thin film formulation of ...
Cached Biology Technology:SleepQuest Achieves Coveted Accreditation 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4
(Date:6/17/2013)... and algae, is a common component of sugar-free gum ... medical field it,s approved by the FDA as ... during surgery as a substance that opens the blood/brain ... Now Profs. Ehud Gazit and Daniel Segal of Tel ... the Sagol School of Neuroscience, along with their colleague ...
(Date:6/17/2013)... 17, 2013) The AGA Research Foundation and Horizon ... future of gastroenterology with the 2013 AGA-Horizon Pharma Fellow ... Prizes. , "In its third year, this competition continues ... embarking on promising careers in basic and clinical research," ... AGA Research Foundation. "We are extremely proud of all ...
(Date:6/17/2013)... worldwide and a major cause is a deadly fungus ... study shows they can also die from this pathogen, ... host that just spreads the disease. , When researchers ... they found at least one strain of this pathogen, ... chytrid fungus, can be fatal to year-old juveniles. However, ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2Horizon Pharma Abstract Prizes recognize promising fellows and students 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... Service Weekly PressPac with news from ACS, 34 peer-reviewed journals ... journal or the American Chemical Society as the source for ... Clothing to crow about: Chicken feather suits and dresses, ... up in warm, cozy sweats made of chicken feathers or ...
... have long known that some repetitive DNA sequences can ... broken during cell divisions. Scientists at Tufts University have ... the cell,s replication process but also thwarts the cell,s ... on this CGG repeat because it is associated with ...
... MADISON University of Wisconsin-Madison researchers have solved the mystery ... release of neurotransmitters and hormones in the brain. ... whose main location and function were unknown until now ... at a control knob, the protein may adjust the release ...
Cached Biology News:American Chemical Society's Weekly PressPac -- Jan. 7, 2009 2American Chemical Society's Weekly PressPac -- Jan. 7, 2009 3American Chemical Society's Weekly PressPac -- Jan. 7, 2009 4American Chemical Society's Weekly PressPac -- Jan. 7, 2009 5American Chemical Society's Weekly PressPac -- Jan. 7, 2009 6American Chemical Society's Weekly PressPac -- Jan. 7, 2009 7American Chemical Society's Weekly PressPac -- Jan. 7, 2009 8American Chemical Society's Weekly PressPac -- Jan. 7, 2009 9Biologists discover link between CGG repeats in DNA and neurological disorders 2Protein that regulates hormones critical to women's health found in pituitary 2Protein that regulates hormones critical to women's health found in pituitary 3
...
... Shakers have the durability to ... 3-high, and the uniformity and ... shake" applications. Heavily built ... our stackers are designed for ...
Improve inventory management with stainless steel red cell canisters; ensure product safety with CO2 or LN2 backup systems. A complete solution for your blood banking needs....
The mini vertical flow workbench is designed to perform PCR protocols in a particle-free environment. The built-in UV light ensures the elimination of any nucleic acid to avoid cross-contamination....
Biology Products: